Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Multicenter Evaluation of the Safety and Effectiveness of the EMBLOK™ Embolic Protection System Compared With No Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement

NCT07129421 is registered in ClinicalTrials.gov with Emblok, Inc. as lead sponsor.

NCT NCT07129421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07129421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Multicenter Evaluation of the Safety and Effectiveness of the EMBLOK™ Embolic Protection System Compared With No Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement
Lead sponsor
Emblok, Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 21, 2025
Completion date
March 15, 2027
Enrollment
560 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve diseases, aortic valve regurgitation, aortic valve replacement, aortic valve stenosis and/or insufficiency